Cargando…
The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study
Background Vitiligo, a chronic autoimmune depigmenting skin disease, affects a significant portion of the global population. One of the topical treatment options for vitiligo is basic fibroblast growth factor (bFGF)-related decapeptide (bFGFrP) 0.1% solution. This study aimed to assess the real-worl...
Autores principales: | Sharma, Aseem, Majid, Imran, Kumar, Hari K, Banodkar, Pravin, Mhatre, Madhulika, Mohod, Bhagyashree, Jaiswal, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403243/ https://www.ncbi.nlm.nih.gov/pubmed/37546028 http://dx.doi.org/10.7759/cureus.41418 |
Ejemplares similares
-
Use of a Stationary Marker Pen as an Alternative to Kumkum and Bindi in Patients with Allergic Contact Dermatitis
por: Mhatre, Madhulika, et al.
Publicado: (2021) -
An Effective Shield to Prevent Unwanted Adverse Effects of the Face after Phototherapy for Lip Vitiligo
por: Daruwalla, Sanober B., et al.
Publicado: (2020) -
Vitiligo-Associated Autoimmune Disorders: A Woman With Vitiligo and Incipient Hypothyroidism
por: Malik, Sara, et al.
Publicado: (2021) -
Diet and Vitiligo: The Story So Far
por: Dutta, Rajoshee R, et al.
Publicado: (2022) -
Vitiligo: A Narrative Review
por: Joge, Rutuja R, et al.
Publicado: (2022)